Memantine Hydrochloride Capsule, Extended Release
FDA Label NDC 70771-1324

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Memantine Hydrochloride (NDC 70771-1324). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

Memantine Hydrochloride Extended-release Capsules, 7 mg

NDC 70771-1321-3

30 Counts

Memantine Hydrochloride Extended-release Capsules, 7 mg (493af1b5 8e55 4b04 B058 7f7d8572244e 01)

Memantine Hydrochloride Extended-release Capsules, 7 mg (493af1b5 8e55 4b04 B058 7f7d8572244e 01)

Memantine Hydrochloride Extended-release Capsules, 14 mg

70771-1322-3

30 Counts

Memantine Hydrochloride Extended-release Capsules, 14 mg (493af1b5 8e55 4b04 B058 7f7d8572244e 02)

Memantine Hydrochloride Extended-release Capsules, 14 mg (493af1b5 8e55 4b04 B058 7f7d8572244e 02)

Memantine Hydrochloride Extended-release Capsules, 21 mg

NDC 70771-1323-3

30 Counts

Memantine Hydrochloride Extended-release Capsules, 21 mg (493af1b5 8e55 4b04 B058 7f7d8572244e 03)

Memantine Hydrochloride Extended-release Capsules, 21 mg (493af1b5 8e55 4b04 B058 7f7d8572244e 03)

Memantine Hydrochloride Extended-release Capsules, 28 mg

NDC 70771-1324-3

30 Counts

Memantine Hydrochloride Extended-release Capsules, 28 mg (493af1b5 8e55 4b04 B058 7f7d8572244e 04)

Memantine Hydrochloride Extended-release Capsules, 28 mg (493af1b5 8e55 4b04 B058 7f7d8572244e 04)

* Please review the disclaimer below.